Leiting Commences Mass Production of Next-Gen Medical VCSEL Phototherapy Modules
Date: 2026/05/18 Hits: 0 [Company News]
With the rapid growth of the global photobiomodulation market, Jiangsu Leiting has commenced mass production of proprietary 650nm/850nm dual-wavelength VCSEL modules in cleanrooms.
Featuring high energy conversion efficiency, narrow spectral half-width (<3nm), and concentrated power density, the module substantially enhances phototherapy efficacy.


























